H23 Monoclonal Antibody Recognizes a Breast Tumor Associated Antigen: Clinical and Molecular Studies

  • I. Tsarfaty
  • S. Chaitchik
  • M. Hareuveni
  • J. Horev
  • A. Hizi
  • D. H. Wreschner
  • I. Keydar


A monoclonal antibody (MoAb) H23 was generated in our laboratory against particles released by the T47D cell line. H23 MoAb recognized specific antigens in 90% of 590 breast tumor biopsies tested by the indirect immunoperoxidase test. Furthermore, the H23 MoAb detects antigens in sera and body fluids of patients with breast carcinoma. The level of serum antigen in 546 individuals tested correlates with the clinical status of the disease and with poor survival. The cDNA coding for the epitope recognized by H23 MoAb was isolated from a cDNA expression library and its sequence and orientation established. The nucleotide sequence showed that the cDNA insert was composed of 60 bp tandem repeats. We have analyzed the RNA isolated from primary human tumors, and it was demonstrated that breast carcinomas expressed the highest levels of mRNA species hybridizing with this cDNA. The gene coding for the cDNA was isolated from a genomic library and encompasses 7.5 kb. A 2.3 kb segment of this gene was found to be an array of tandem 60 bp repeat units whilst the remaining parts of the gene do not contain these repeats. The fact that these non-repeat sequences hybridize to identical mRNA species, has led to ongoing studies aimed at their further characterization.


Antigen Level mRNA Species cDNA Insert cDNA Expression Library T47D Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. Schlom, D. Colcher, P.A. Hold, F. Greiner, M. Weeks, P.B. Fisher, P. Noguchi, S. Peskta, and D. Kufe, 1985, Adv. in Cancer Res., 43:143.CrossRefGoogle Scholar
  2. 2.
    F. Greiner, P. Horan-Hand, D. Colcher, M. Weeks, A. Thor, P. Noguchi, S. Peskta, and J. Schlom, 1987, J. Lab. Clinical Med. , 109:244.Google Scholar
  3. 3.
    J. Taylor-Papadimit, Jou J. Peterson, J. Arklie, R.L. Burchell, R.L. Ceriani, and W.F. Bodmer, 1981, Int. J. Cancer, 28:17.CrossRefGoogle Scholar
  4. 4.
    R.L. Ceriani, J. Peterson, J.Y. Lee, R. Moncada, and E.W. Blank, 1983, Somatic Cell Genet. ,9:415.PubMedCrossRefGoogle Scholar
  5. 5.
    D. Kufe, G. Inghiami, M. Abe, D. Hayes, H. Gusti-Wheeler, and J. Schlom, 1984, Hybridoma. , 3:223.PubMedCrossRefGoogle Scholar
  6. 6.
    J. Hilkens, J. Hilgers, F. Buijs, P.H. Hageman, D. Schol, G. Van Doornewaard, and J. Van den Tweel, 1984, In: Protides of the Biological Fluids. 31, H. Peeters ed. Pergamon Press.Google Scholar
  7. 7.
    J. Schlom, D. Wunderlich, and Y.A. Teramoto, 1984, Proc. Nat. Acad. Sci. , (USA) 77:6841 .CrossRefGoogle Scholar
  8. 8.
    I. Keydar, I. Tsarfaty, N.I. Smorodinsky, E. Sahar, Y. Shoenfeld, and S. Chaitchik, 1987, In: New Experimental Modalities in the Control of Neoplasia, ed. P. Chandra, Plenum Press, Ch 9.Google Scholar
  9. 9.
    Y. Shoenfeld, A. Hizi, R. Tal, N.I. Smorodinsky, G. Lavy, C. Mor, S. Schteren, I. Mammon, J. Pinhas, and I. Keydar, 1987, Cancer, 59:43.PubMedCrossRefGoogle Scholar
  10. 10.
    I. Keydar, T. Ohno, R. Nayak, R. Sweet, F. Simoni, F. Weiss, S. Karby, R. Mesa-Tejada, and S. Spiegelman, 1984, Proc. Nat. Acad. Sci. , (USA) 81 :4188PubMedCrossRefGoogle Scholar
  11. 11.
    J. Kolher, and C. Milstein, 1975, Nature. 256:495CrossRefGoogle Scholar
  12. 12.
    I. Keydar, G. Selzer, S. Chaitchik, M. Hareuveni, S. Karby, and A. Hizi, 1982, Eur. J. Cancer & Clin. Oncol. , 3. D.F. 18:1321CrossRefGoogle Scholar
  13. 13.
    D. F. Hayes, T. Ohno, M. Abe, H. Sekine, and D.W. Kufe, 1985, Clin. Invest. , 75:1671 .CrossRefGoogle Scholar
  14. 14.
    L.D. Papsidero, G.A. Chrogan, M.J. O’Connell, L.A. Valenzuela, T. Nemoto, and T.M. Chu. 1983 Cancer Res. ,43:1741PubMedGoogle Scholar
  15. 15.
    L.D. Papsidero, T. Nemoto, G.A. Chroghan, and T.M. Chu, 1984, Cancer Res. , 44:4653.PubMedGoogle Scholar
  16. 16.
    J. Siddiqui, M. Abe, D. Hayes, E. Shani, E. Yunis, and D. Kufe, 1988, Proc. Natl. Acad. Sci. , USA 85:2320.PubMedCrossRefGoogle Scholar
  17. 17.
    D.M. Swallow, S. Gendler, B. Griffiths, G. Corney, J. Taylor Papadimitriou, and M. Bramwell, 1987, Nature London, 328:82.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • I. Tsarfaty
    • 1
  • S. Chaitchik
    • 2
  • M. Hareuveni
    • 1
  • J. Horev
    • 1
  • A. Hizi
    • 3
  • D. H. Wreschner
    • 1
  • I. Keydar
    • 1
  1. 1.Department of Microbiology, the George S. Wise Faculty of Life SciencesTel Aviv UniversityTel AvivIsrael
  2. 2.Department of Oncology, Tel Aviv Medical Center Sackler School of MedicineTel Aviv UniversityIsrael
  3. 3.Department of Histology and Cell Biology, Sackler School of MedicineTel Aviv UniversityIsrael

Personalised recommendations